(Q42989131)

12 November 2017

title

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy (English)

1 reference

12 November 2017

1 reference

1 reference

F C Bekkering

1

1 reference

12 November 2017

J T Brouwer

2

1 reference

12 November 2017

G Leroux-Roels

3

1 reference

12 November 2017

H Van Vlierberghe

4

1 reference

12 November 2017

A Elewaut

5

1 reference

12 November 2017

S W Schalm

6

1 reference

12 November 2017

publication date

1 June 1998

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

28

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

960-964

1 reference

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

International collaborative study on the second EUROHEP HCV-RNA reference panel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980343-7

7 January 2021

10.1016/S0168-8278(98)80343-7

Identifiers

DOI

1 reference

12 November 2017

1 reference